In the largest study on genetic modifiers in FTD-GRN, carriers of the TMEM106B protective haplotype (‘G’ allele of rs3173615) had 50% lower odds of developing disease symptoms compared to non-protective haplotype carriers [68]. The gene discussed is TMEM106B; the disease is frontotemporal dementia.